House Science Committee hearing spotlights EPA review delays and risks to independent science as industry warns competitiveness at stake Industry witnesses told the House Science, Space and Technology Committee that slow EPA chemical reviews and regulatory uncertainty are pushing U.S. innovation overseas, while former EPA officials and Democrats warned that cuts to the agency's independent research office risk public‑health protections.

As the House Science Committee debates EPA review delays, industry leaders warn that America's innovation in chemistry is at serious risk of being pushed overseas.

Get the details

#US #EnvironmentalPolicy #WashingtonChemistry #PublicHealth #CitizenPortal #InnovationChallenges